Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1757-2215
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients ; volume:14 ; number:1 ; day:8 ; month:1 ; year:2021 ; pages:1-8 ; date:12.2021
Journal of ovarian research ; 14, Heft 1 (8.1.2021), 1-8, 12.2021

Urheber
Wang, Wu-yun
Wu, Miao-fang
Wu, Dong-bing
Wang, Li-juan
Li, Hui
Lin, Zhong-qiu
Li, Jing
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13048-021-00764-6
URN
urn:nbn:de:101:1-2021030421365120811222
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:29 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Wang, Wu-yun
  • Wu, Miao-fang
  • Wu, Dong-bing
  • Wang, Li-juan
  • Li, Hui
  • Lin, Zhong-qiu
  • Li, Jing
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion

Influence of hyperthermic intraperitoneal chemotherapy on renal blood perfusion

Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC)

Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit?

Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit?

Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy

Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy

Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy

Verbundene Objekte